[HTML][HTML] Biological drug and drug delivery-mediated immunotherapy

Q Xiao, X Li, Y Li, Z Wu, C Xu, Z Chen, W He - Acta Pharmaceutica Sinica B, 2021 - Elsevier
The initiation and development of major inflammatory diseases, ie, cancer, vascular
inflammation, and some autoimmune diseases are closely linked to the immune system …

Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management

ETH Yeh, AT Tong, DJ Lenihan, SW Yusuf, J Swafford… - Circulation, 2004 - Am Heart Assoc
The cardiotoxicity of anticancer agents can lead to significant complications that can affect
patients being treated for various malignancies. The severity of such toxicity depends on …

Allergy diagnostic testing: an updated practice parameter

IL Bernstein, JT Li, DI Bernstein, R Hamilton… - Annals of allergy …, 2008 - annallergy.org
The major emphasis of this updated version of Practice Parameters for Allergy Diagnostic
Testing is focused on how technological refinements and their validations during the past …

The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators

M Centola, G Wood, DM Frucht, J Galon… - Blood, The Journal …, 2000 - ashpublications.org
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of
fever and neutrophil-mediated serosal inflammation. We recently identified the gene causing …

Side Effects of Interferon-α Therapy

S Sleijfer, M Bannink, AR Van Gool, WHJ Kruit… - Pharmacy world and …, 2005 - Springer
Aim Interferon-α (IFN-α) has been extensively explored for its efficacy in various disease
conditions and is currently used as a standard treatment in several of these. Its use is …

The environment and autoimmune thyroid diseases

MF Prummel, T Strieder… - European Journal of …, 2004 - academic.oup.com
Genetic factors play an important role in the pathogenesis of autoimmune thyroid disease
(AITD) and it has been calculated that 80% of the susceptibility to develop Graves' disease is …

Multiple sclerosis: side effects of interferon beta therapy and their management

EU Walther, R Hohlfeld - Neurology, 1999 - AAN Enterprises
Article abstract Interferon beta (IFNβ) reduces the relapse rate, disease activity as measured
by serial MRI scanning, and disease progression of MS. Therapy with IFNβ may be …

[PDF][PDF] Infusion reactions: diagnosis, assessment, and management

WH Vogel - Clinical journal of oncology nursing, 2010 - Citeseer
Reviewing the body's immune response to a foreign substance is helpful to comprehend the
origin of an infusion reaction. Essentially, the administration of any foreign drug is likely to …

Living with chronic illness: A contextualized, self-regulation approach

H Leventhal, E Halm, C Horowitz… - The Sage handbook of …, 2004 - torrossa.com
As the number of chronic diseases is legion, each having a different impact on function and
quality of life, our chapter must necessarily be limited in scope. The contents of our chapter …

Interferon-α and autoimmune thyroid disease

MF Prummel, P Laurberg - Thyroid, 2003 - liebertpub.com
Interferon-α (IFNα) is the main therapeutic agent in patients infected with the hepatitis C virus
(HCV). It is rather safe, but is known to induce the production of autoantibodies and can lead …